Reliability and Validity of the Adolescent Idiopathic Scoliosis - Truncal Anterior Asymmetry Scoliosis Questionnaire (TAASQ)

November 28, 2025 updated by: Tuğba GÖNEN, Hasan Kalyoncu University

Reliability and Validity of the Turkish Version of the Adolescent Idiopathic Scoliosis-Truncal Anterior Asymmetry Scoliosis Questionnaire (TAASQ)

The survey examines how individuals with scoliosis define themselves and their physical appearance. Our aim in this study was to translate this survey into Turkish and demonstrate its reliability and validity.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

The "Adolescent Idiopathic Scoliosis-Truncal Anterior Asymmetry Scoliosis Questionnaire" was developed to investigate how individuals with scoliosis feel about their frontal body appearance. The survey was developed by BS Lonner and colleagues and published in 2023. It consists of 14 questions. Female patients with scoliosis are asked to answer these questions personally. Permission for the Turkish validity and reliability of the survey was requested and received on November 18, 2024. The survey questions how individuals with scoliosis define themselves and their physical perception of their bodies. The aim of this study is to translate this survey into Turkish and demonstrate its reliability and validity. This study will examine the test-retest reliability and internal consistency of the Adolescent Idiopathic Scoliosis-Truncal Anterior Asymmetry Scoliosis Questionnaire (TAASQ), and its validity with the SRS-22 and Walter Reed questionnaires. This study was designed as an intra-rater and intra-rater reliability and structural validity study.

Study Type

Observational

Enrollment (Estimated)

29

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey (Türkiye)
    • Gaziantep
      • Gaziantep, Gaziantep, Turkey (Türkiye), (505) 090-5846
        • Hasan Kalyoncu University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The sample group consisted of female adolescents with idiopathic scoliosis who volunteered for the study and met the inclusion criteria. Convenience sampling was used in sample selection.

Description

Inclusion Criteria:

  • Adolescent idiopathic diagnosis

Exclusion Criteria:

  • Individuals who did not agree to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Scoliosis Group
The study sample consists of female individuals between the ages of 10-18 diagnosed with adolescent idiopathic scoliosis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adolescent Idiopathic Scoliosis-Truncal Anterior Asymmetry Scoliosis Questionnaire (TAASQ)
Time Frame: through of the study, average 4 months
The "Adolescent Idiopathic Scoliosis-Truncal Anterior Asymmetry Scoliosis Questionnaire" was developed to ask individuals with scoliosis how they feel about the frontal appearance of their bodies. The survey was developed by BS Lonner and colleagues and published in 2023. The survey consists of 14 questions. Female patients with scoliosis are asked to answer these questions themselves.A high score indicates poor body appearance.
through of the study, average 4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scoliosis Research Society-22 (SRS-22)
Time Frame: through of the study, average 4 months
The SRS-22 questionnaire includes five domains. The domains and the number of questions in them are as follows: function/activity (5), pain (5), self-image/appearance (5), mental health (5), and satisfaction with management (2). The combination of the first 4 domains is labeled subtotal. The mental health questions are adapted with permission from SF-36. The scoring scale ranges from 5 as best to 1 as worst.
through of the study, average 4 months
Walter Reed Visual Assessment Scale
Time Frame: through of the study, average 4 months
The Walter Reed Visual Assessment Scale (WRGDS) was developed by Pineda et al. in 2006 to measure the perceived severity of deformity in individuals with scoliosis, using visual patterns. The scale assesses spinal deformity, rib protrusion, lumbar protrusion, thoracic deformity, trunk imbalance, scapular asymmetry, and shoulder asymmetry. In each section, the individual is asked to mark the image closest to their own image from five different visuals representing the degree of deformity. Scoring is performed with a score of 1 representing the image with minimal deformity and a score of 5 representing the image with maximum deformity. A high score indicates a high perceived deformity.
through of the study, average 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hasan Kalyoncu University

Investigators

  • Principal Investigator: Tuğba GÖNEN, Asisst. Prof. Dr., Hasan Kalyoncu University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 15, 2025

Primary Completion (Estimated)

February 15, 2026

Study Completion (Estimated)

March 15, 2026

Study Registration Dates

First Submitted

November 28, 2025

First Submitted That Met QC Criteria

November 28, 2025

First Posted (Actual)

December 10, 2025

Study Record Updates

Last Update Posted (Actual)

December 10, 2025

Last Update Submitted That Met QC Criteria

November 28, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024/49

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe